Literature DB >> 14655781

Successful treatment of recalcitrant palmoplantar psoriasis with etanercept.

Jeffrey M Weinberg1.   

Abstract

Palmoplantar psoriasis is a disabling condition characterized by recurrent crops of sterile pustules with associated erythema, fissuring, and scaling. Genetic and environmental factors have been implicated in its etiology. Topical treatments are frequently ineffective. Other treatment options include systemic retinoids, psoralen-UVA (PUVA), and a combination of both. We report a case of successful treatment of recalcitrant palmoplantar psoriasis with etanercept in a 59-year-old woman unresponsive to other treatment modalities.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14655781

Source DB:  PubMed          Journal:  Cutis        ISSN： 0011-4162


  4 in total

1.  Etanercept in psoriasis: the evidence of its therapeutic impact.

Authors:  Andrew Thomson
Journal:  Core Evid       Date:  2007-03-31

2.  Efficacy of adalimumab across subgroups of patients with moderate-to-severe chronic plaque psoriasis of the hands and/or feet: post hoc analysis of REACH.

Authors:  Y Poulin; J J Crowley; R G Langley; K Unnebrink; O M Goldblum; W C Valdecantos
Journal:  J Eur Acad Dermatol Venereol       Date:  2013-06-22       Impact factor: 6.166

Review 3.  The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review.

Authors:  Isabelle M Sanchez; Eric Sorenson; Ethan Levin; Wilson Liao
Journal:  Dermatol Ther (Heidelb)       Date:  2017-11-15

4.  A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 2.

Authors:  Bruce E Strober; Jennifer Clay Cather; David Cohen; Jeffrey J Crowley; Kenneth B Gordon; Alice B Gottlieb; Arthur F Kavanaugh; Neil J Korman; Gerald G Krueger; Craig L Leonardi; Sergio Schwartzman; Jeffrey M Sobell; Gary E Solomon; Melodie Young
Journal:  Dermatol Ther (Heidelb)       Date:  2012-03-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.